RxDoctor Payments Data

James Kolbeck, MD

Interventional Cardiology · Saint Paul, MNNPI 1821209792

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $3,036 of the $5,053 with a category attached, or 60.1%. 7 manufacturers reported payments, led by Edwards Lifesciences at 59.2% of the total. That places this record below the midpoint for interventional cardiology clinicians in MN, where the typical reported total is $5,396.

$5,053in general payments, 2019–2025

Across 72 payments — averaging $70.18 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Edwards Lifesciences$3K
  • Abbott$1K
  • Medtronic$321
  • Cardiovascular Systems Inc.$188
  • Abiomed$86
  • Stryker$16
  • plus $14 from 1 others

What the payments were for

  • Travel & lodging$2,01740%
  • Food & beverage$3,03660%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$5,053 in reported general payments places this provider in the 45th percentile of 84 interventional cardiology providers in Minnesota.

See all interventional cardiology providers in Minnesota

Medicare billing

Part B allowed, 2024
$155,866
Medicare patients
316
Services billed
818

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban252$298,351
Repatha SureclickEvolocumab119$127,087
XareltoRivaroxaban69$85,135
EntrestoSacubitril/Valsartan27$32,037
Praluent PenAlirocumab33$25,830
Metoprolol Succinate486$7,823
Atorvastatin Calcium309$3,870
Rosuvastatin Calcium172$3,223
Bumetanide45$3,133
Losartan Potassium167$2,598
ClopidogrelClopidogrel Bisulfate173$2,486
Isosorbide Mononitrate ErIsosorbide Mononitrate77$1,813
SotalolSotalol Hcl65$1,603
Metoprolol Tartrate119$1,488
Furosemide217$1,396

Paid to pharmacies, not to this prescriber.

Other interventional cardiology in Saint Paul

See the full list for Minnesota

Where these figures come from

Is this you, or does something look wrong? →